Shares of HCA Healthcare, Inc. (NYSE:HCA – Get Rating) have earned an average rating of “Buy” from the twenty-six brokerages that are presently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $258.90.
Several research analysts have weighed in on the stock. UBS Group lowered their target price on shares of HCA Healthcare from $289.00 to $241.00 and set a “buy” rating for the company in a research note on Tuesday, April 26th. Citigroup lowered their price objective on shares of HCA Healthcare from $277.00 to $254.00 and set a “buy” rating for the company in a research note on Monday, April 25th. SVB Leerink lowered their price objective on shares of HCA Healthcare from $304.00 to $273.00 and set an “outperform” rating for the company in a research note on Monday, April 25th. Mizuho lowered their price objective on shares of HCA Healthcare from $290.00 to $260.00 in a research note on Tuesday. Finally, Royal Bank of Canada lowered their price objective on shares of HCA Healthcare from $291.00 to $267.00 and set an “outperform” rating for the company in a research note on Monday, April 25th.
In other HCA Healthcare news, major shareholder Thomas F. Frist, Jr. purchased 89,100 shares of HCA Healthcare stock in a transaction that occurred on Monday, May 2nd. The stock was purchased at an average price of $211.93 per share, for a total transaction of $18,882,963.00. Following the transaction, the insider now directly owns 478,955 shares in the company, valued at $101,504,933.15. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Andrea B. Smith acquired 1,160 shares of the company’s stock in a transaction on Thursday, April 28th. The stock was purchased at an average cost of $213.63 per share, for a total transaction of $247,810.80. Following the completion of the purchase, the director now directly owns 2,239 shares in the company, valued at approximately $478,317.57. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 91,370 shares of company stock valued at $19,373,375 and sold 32,655 shares valued at $8,241,766. 1.50% of the stock is owned by corporate insiders.
Shares of HCA opened at $224.19 on Friday. The company has a current ratio of 1.43, a quick ratio of 1.24 and a debt-to-equity ratio of 87.46. HCA Healthcare has a 12-month low of $199.76 and a 12-month high of $279.02. The firm has a 50-day moving average price of $251.15 and a 200 day moving average price of $247.24. The firm has a market capitalization of $67.71 billion, a P/E ratio of 10.55, a P/E/G ratio of 1.30 and a beta of 1.61.
HCA Healthcare (NYSE:HCA – Get Rating) last announced its earnings results on Friday, April 22nd. The company reported $4.12 earnings per share for the quarter, missing the consensus estimate of $4.25 by ($0.13). The company had revenue of $14.95 billion for the quarter, compared to analysts’ expectations of $14.72 billion. HCA Healthcare had a return on equity of 405.72% and a net margin of 11.40%. The company’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same period last year, the business earned $4.14 EPS. Equities research analysts predict that HCA Healthcare will post 17.15 earnings per share for the current fiscal year.
HCA Healthcare announced that its board has approved a stock repurchase plan on Thursday, January 27th that allows the company to repurchase $8.00 billion in shares. This repurchase authorization allows the company to reacquire up to 10.9% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board of directors believes its shares are undervalued.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 30th. Shareholders of record on Thursday, June 16th will be issued a dividend of $0.56 per share. The ex-dividend date is Wednesday, June 15th. This represents a $2.24 dividend on an annualized basis and a yield of 1.00%. HCA Healthcare’s payout ratio is currently 10.54%.
HCA Healthcare Company Profile (Get Rating)
HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
- Get a free copy of the StockNews.com research report on HCA Healthcare (HCA)
- Expedia or Bookings Holdings: Which Stock Should You Travel With?
- Is This The Bottom For Papa John’s International?
- Kellogg Company Flexes Pricing Power, Shares Move Higher
- Peak Growth Is Over For Etsy
- Uber Fails To Impress
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.